Physician profile
Mark J Burstein
NPI 1972788214
$1,748.48
in general payments reported to CMS, 2019-2025
17 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $87.90 · 2021: $176 · 2022: $184 · 2023: $291 · 2024: $391 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,067.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $589.15 | 2021-2025 | Nucala |
| Optinose US, INC. | $404.71 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $212.85 | 2020-2025 | Dupixent |
| Genzyme Corporation | $94.89 | 2022-2024 | |
| Stryker Corporation | $90.86 | 2019-2025 | Audion Et Dilation System, Scopis Ent, Latera |
| Acclarent, INC | $64.19 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $59.01 | 2021-2023 | |
| Arbor Pharmaceuticals, INC. | $55.32 | 2019-2020 | |
| Alk-Abello, INC | $25.58 | 2019 | |
| Axogen | $23.60 | 2019 | |
| Aerin Medical INC. | $23.18 | 2025 | |
| Inspire Medical Systems, INC. | $23.13 | 2024 | Inspire |
| Ibsa Pharma INC. | $20.81 | 2019 | |
| Lilly USA, LLC | $19.26 | 2020 | |
| Medtronic, INC. | $14.24 | 2023 | Sinuva |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $13.96 | 2024 | Ryaltris |
| Olympus America INC. | $13.74 | 2025 | Olympus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Burstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.